Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05983302
PHASE2/PHASE3

Elimination of Odor and Treatment of Malodorous Recalcitrant Wounds by Using Supraz and PRP-FG Versus Standard of Care

Sponsor: Mashhad University of Medical Sciences

View on ClinicalTrials.gov

Summary

The aim of this study is to eliminate the malodorous of chronic wound and increase the chance of the healing of recalcitrant wounds by using the repairing gel (supraz gel) which has the approved components in wound healing and platelet-rich plasma-fibrin glue.

Official title: Repairing Gel (Supraz) and Platelet-rich Plasma-Fibrin Glue (PRP-FG) in Eliminating Odor and Healing the Malodorous Chronic Wounds Versus Standard of Care

Key Details

Gender

All

Age Range

Any - Any

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2023-08-20

Completion Date

2027-03-20

Last Updated

2026-05-06

Healthy Volunteers

No

Interventions

DRUG

Platelet-Rich Plasma-Fibrin Glue

The first intervention group includes 10 patients with chronic wounds who, despite common treatment, will be undergone PRP-FG intervention for 8 weeks.

DRUG

Repairing Gel

The second intervention group includes 10 patients with chronic wounds who, despite common treatment, will be undergone the repairing gel with approved wound healing components in the form of gel for 8 weeks.

DRUG

Repairing Gel and Platelet-Rich Plasma-Fibrin Glue

The third intervention group includes 10 patients with chronic wounds who, despite common treatment, will be undergone the repairing gel with approved wound healing components in the form of gel and PRP-FG for 8 weeks.

OTHER

Classical wound irrigation (control)

For 10 patients with chronic wounds, only the classical wound irrigation by normal saline will be continued for 8 weeks.

Locations (1)

Mashhad University of Medical Sciences

Mashhad, Razavi Khorasan Province, Iran